The purpose of the Clinical Laboratory Improvement Amendment (CLIA) is to?
o Prevent the exposure of employees to bloodborne pathogens in the workplace
O Prevent errors ir technique during laboratory testing
O Improve the quality of laboratory testing in the United States
Ensure safety in the laboratory

Answer:

Improve the quality of lab testing in the US.

Explanation:

In general terms, the CLIA regulations establish quality standards for laboratory testing performed on specimens from humans, such as blood, body fluid and tissue, for the purpose of diagnosis, prevention, or treatment of disease, or assessment of health

A drug's generic name is the official drug name found in the
A. National Institutes of Health.
B. Center for Disease Control.
C.U.S Pharmacopeia National Formulary.
D. Physician's Desk Reference.

The physical or structural character of a dose is called the
A. dosage strength available (DA).
B. dose to be given (DG).
C. dosage form (DF).
D. dose ordered (DO).

Which of the following can affect how quickly pollutants move away from an area?

Which of the following is always included on a prescription?

A. Doctor's name
B. Health insurance information
C. Expiration date
D. Medication name

A drug's generic name is the official drug name found in the
A. National Institutes of Health.
B. Center for Disease Control.
C. U.S Pharmacopeia National Formulary.
D. Physician's Desk Reference.

How is information referenced in the Geriatric Dosage Handbook?
A. By manufacturer
B. By the year it was manufactured
C. By brand and generic name
D. By category

What is a result of the nation's inactivity?
A.
It has prevented death from cardiovascular disease.
B.
It has caused the percentage of overweight young people to decrease.
C.
It has contributed to the increasing number of cases of cancer and heart disease.
D.
It has helped to improve the nation's healthcare budget.